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ABSTRACT 
 
Objectives: To explore the outcome of fetuses with a prenatal diagnosis of fetal ovarian cysts. 
Methods: Medline and Embase databases were searched. The following outcomes were explored: 
resolution of the cyst, change of ultrasound pattern, occurrence of ovarian torsion and intra-cystic 
haemorrhage, need for surgery, need for oophorectomy, detection rate of prenatal ultrasound in 
correctly identifying ovarian cysts, type of ovarian cyst at histopathological analysis and intra-
uterine treatment. Meta-analyses using individual data random-effect logistic regression and meta-
analyses of proportion were used to analyse the data. Quality assessment of the included studies was 
performed using the Newcastle-Ottawa Scale. 
Results: Thirty-four studies (954 fetuses) were included. 54.6% (95% CI 47.0-62.0) of the cysts 
regressed either during pregnancy or after birth. The likelihood of resolution was significantly lower 
in complex vs simple cysts (OR: 0.15, 95% CI 0.10-0.23) and in those ≥ 40 compared to<40 mm 
(OR: 0.03, 95% CI 0.01-0.06). Change in ultrasound pattern was associated with an increased risk 
of ovarian loss (PP: 57.7%, 95% CI 42.9—71.8). The risk of ovarian torsion was significantly 
higher in cysts ≥ compared to those < 40 mm (OR: 30.8, 95% CI 8.6-110). The risk of having 
surgery was higher in patients with cysts ≥ compared to <40 mm (OR: 64.4, 95% CI 23.6-175) and 
in complex cysts compared to simple cysts, irrespective of the cyst size. In cases undergoing 
prenatal aspiration of the cyst, the rate of recurrence was 37.9% (95% CI 14.8-64.3), while torsion 
and haemorrhage were diagnosed after birth in 10.8% (95% CI 4.4-19.7) and 9.7% (95% CI 3.7-
18.3) of the cases treated. Finally, 17.7% (95% CI 9.3-,28) of fetuses undergoing fetal therapy had 
surgery after birth. 
Conclusion: Cysts size and appearance are the major determinants of perinatal outcome in these 
anomalies.  
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INTRODUCTION 
 
Ovarian cysts are the most common abdominal anomalies diagnosed in female fetuses with an 
estimated incidence of about 1 in 2600 pregnancies1. Although the pathophysiology of ovarian cysts 
has not yet been fully elucidated, they are usually benign functional anomalies resulting from 
excessive stimulation of fetal ovaries by placental and maternal hormones. Ovarian cysts are 
common in pregnancies complicated by maternal diabetes, pre-eclampsia or Rhesus 
isoimmunisation. They are frequently diagnosed during the third trimester, especially after 28 
weeks of gestation1,2. Ovarian cysts are divided into two categories according to their sonographic 
appearance. The first category includes simple cysts which are usually anechoic, round, unilocular 
and thin walled lesions larger than 2 cm. The second category includes complex thick walled, 
heterogeneous, containing hyperechoic components, free-floating material or intra-cystic septations 
and is commonly considered the result of torsion or intra-cystic haemorrhage3. 
Optimal management of fetal ovarian cysts is unclear. The evolution of these anomalies is variable 
Although the majority of them regress either during pregnancy or after birth, torsion and 
haemorrhage can occur antenatally, thus increasing the risk of surgical intervention and ovarian 
loss. Pre-natal aspiration of the cyst is occasionally performed, especially in case of large lesions, in 
order to prevent intra-uterine torsion which may lead to ovarian auto-amputation or the need for 
oophorectomy. However, whether it improves the neonatal outcome in these fetuses is yet to be 
established. Furthermore, the accuracy of antenatal ultrasound in correctly identifying ovarian cysts 
prenatally is unknown. Gastrointestinal, renal and genital anomalies are commonly misdiagnosed as 
ovarian cysts2. Finally, it is yet to be ascertained whether the ultrasound appearance of the cyst can 
predict the post-natal outcome or be used to guide the prenatal management in these cases. 
The aim of this systematic review was to explore the outcome of ovarian cysts diagnosed prenatally 
and to quantify the accuracy of antenatal ultrasound in correctly identifying these anomalies.
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METHODS 
 
Protocol, eligibility criteria, information sources and search 
This review was performed according to an a-priori designed protocol and recommended for 
systematic reviews and meta-analysis4. Medline and Embase databases were searched electronically 
on the 11.02.2016 utilizing combinations of the relevant medical subject heading (MeSH) terms, 
key words, and word variants for “ovarian cysts”, “ultrasound” and “outcome” (Supplementary 
Table 1). The search and selection criteria were restricted to English language. Reference lists of 
relevant articles and reviews were hand searched for additional reports. Prisma guidelines were 
followed5.  
The study was registered with the PROSPERO database (Registration number: CRD42016035594). 
 
Study selection, data collection and data items 
Two authors (FB, LM) reviewed all abstracts independently. Agreement regarding potential 
relevance was reached by consensus; full text copies of those papers were obtained and the same 
two reviewers independently extracted relevant data regarding study characteristics and pregnancy 
outcome. Inconsistencies were discussed by the reviewers and consensus reached or by discussion 
with a third author. If more than one study was published for the same cohort with identical 
endpoints, the report containing the most comprehensive information on the population was 
included to avoid overlapping populations. For those articles in which information was not reported 
but the methodology was such that this information would have been recorded initially, the authors 
were contacted. 
Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale 
(NOS); according to NOS, each study is judged on three broad perspectives: the selection of the 
study groups; the comparability of the groups; and the ascertainment outcome of interest6. 
Assessment of the selection of a study includes the evaluation of the representativeness of the 
exposed cohort, selection of the non-exposed cohort, ascertainment of exposure and the 
demonstration that outcome of interest was not present at start of study. Assessment of the 
comparability of the study includes the evaluation of the comparability of cohorts on the basis of the 
design or analysis. Finally, the ascertainment of the outcome of interest includes the evaluation of 
the type of the assessment of the outcome of interest, length and adequacy of follow-up6. According 
to NOS a study can be awarded a maximum of one star for each numbered item within the Selection 
and Outcome categories. A maximum of two stars can be given for Comparability.  
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The incidence of the following outcomes was analysed in fetuses with a prenatal diagnosis of an 
ovarian cyst: 
• Resolution of the cyst in utero or after birth. 
• Change of ultrasound pattern from simple to complex cyst.  
• Occurrence of ovarian torsion and intra-cystic haemorrhage. 
• Need for surgery. 
• Ovarian loss due to oophorectomy or salpingo-oophorectomy. 
• False positive rate of prenatal ultrasound. 
• Histopathological type of the ovarian cyst 
• Intra-uterine treatment. 
 
Cases undergoing prenatal intervention (cyst aspiration) were evaluated separately in terms of: 
• Resolution of the cyst. 
• Recurrence of the cyst. 
• Increase in cyst size after aspiration. 
• Change of ultrasound pattern after intervention. 
• Evidence of torsion or haemorrhage after intervention or at birth. 
• Need for surgery. 
• Preterm birth (PTB) or miscarriage due to the invasive procedure 
All these outcomes were assessed in the overall population of fetuses with a prenatal diagnosis of an 
ovarian cyst. Furthermore, a sub-analysis according to the appearance (simple vs complex) and size 
of the cyst (< vs ≥ 40 mm) was also carried out. The choice for this cut-off was based upon the fact 
that this has been commonly reported to represent the highest centile of cyst size in the published 
literature. 
 
For the ascertainment of the resolution and the change in ultrasound appearance of the cyst, the 
anomalies were categorised according to their first ultrasound appearance and size, while the 
prevalence and risk of torsion, haemorrhage, surgery and need for oophorectomy were ascertained 
by looking at the post-natal ultrasound examination or, if not available, the last scan in pregnancy. 
Cases undergone cyst aspiration in utero were analysed separately and not included in the main 
analyses. PTB or miscarriage was considered to be caused by fetal therapy whether occurring 
within 15 days from the intervention. 
Only studies reporting a prenatal diagnosis of ovarian cyst were considered suitable for the 
inclusion in the current systematic review. Post-natal studies or studies from which cases diagnosed 
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prenatally could not be extracted were excluded. Paediatric and surgical series including only 
symptomatic cases or patients undergoing surgical treatment were also excluded. Studies published 
before 2000 were not included, as we considered that advances in prenatal imaging techniques, 
improvements in the diagnosis and definition of fetal anomalies make these studies less relevant. 
Finally, studies not providing a clear classification of the anomaly were not considered suitable for 
the inclusion in the current review.  
 
Only full text articles were considered eligible for the inclusion. Case reports, conference abstracts 
and case series with fewer than 3 cases of suspected ovarian cysts, irrespective of the fact that the 
anomalies were isolated or not, were also excluded in order to avoid publication bias. 
 
Statistical analysis 
The strength of association between ultrasound characteristics of the cysts and each observed 
outcome was explored. For the quantification of the incidence of these outcomes, meta-analyses of 
proportions using random effect model were used to combine data. Funnel plots displaying the 
outcome rate from individual studies versus their precision (1/standard error) were carried out with 
an exploratory aim. Tests for funnel plot asymmetry were not used when the total number of 
publications included for each outcome was less than ten (Supplementary material). In this case, the 
power of the tests is too low to distinguish chance from real asymmetry.7-10 Between-study 
heterogeneity was explored using the I2 statistic, which represents the percentage of between-study 
variation that is due to heterogeneity rather than chance10.  
 
Furthermore, we evaluated separately the association between ovarian cysts type (complex or 
simple) and size (≥40mm or <40 mm) and six clinical outcomes (change of US pattern: simple 
cases becoming complex; resolution; torsion; haemorrhage; surgery; ovarian loss / oophorectomy). 
We also stratified the meta-analyses exploring any combination of cysts type and size, thus 
performing a total of 8 direct comparisons for each of the outcomes (excluding change of US 
pattern): (1) complex vs simple cysts; (2) ≥40mm vs <40mm cysts; (3) simple cysts ≥40mm vs <40 
mm; (4) complex cysts ≥40mm vs <40 mm; (5) complex cysts ≥40 mm vs simple cysts ≥40mm; (6) 
complex cysts <40mm vs simple cysts ≥40mm; (7) complex cysts ≥40mm vs simple cysts <40mm; 
and (8) complex cysts <40mm vs simple cysts <40mm. 
We included observational cohort studies in which: (a) many comparisons reported zero events in 
one groups; (b) several comparisons reported zero events in both groups; (c) exposed and 
unexposed group sizes were frequently severely unbalanced. In such a case, many of the most 
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commonly used meta-analytical methods - including those using risk difference (which could be 
used to handle total zero event studies) - can produce biased estimates when events are rare11,12. 
When many studies are also substantially imbalanced, the best performing methods are the Mantel-
Haenszel odds ratio without zero-cell continuity corrections, logistic regression and an exact 
method13,14. Mantel-Haenszel odds ratios cannot be computed in studies reporting zero events in 
both groups, the exclusion of which may however cause a relevant loss of information and the 
potential inflation of the magnitude of the pooled exposure effect.11 Therefore, to keep all studies 
into the analyses, we performed all meta-analyses using individual data random-effect logistic 
regression, with single study as the cluster unit. The pooled datasets with individual data were 
reconstructed using published 2X2 tables. When one of the overall pooled arms showed no events, 
we used exact logistic regression. 
As a likely consequence of non-randomization, dissimilarity of the populations and lack of fixed 
criteria for when to treat, several of the comparisons showed an extreme imbalance in the success 
rate between the groups being compared (e.g. 44/67 vs 0/69). Besides the computational issues, in 
such cases the odds ratios may be of limited interest and sensitivity and specificity may be more 
informative. We thus computed the overall sensitivity and specificity (and related 95% confidence 
intervals - CI) for each comparison using according to the efficient-score method (corrected for 
continuity) described by Newcombe13. 
All analyses were performed using Stata version 13.1 (Stata Corp., College Station, TX, 2013). 
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RESULTS 
 
Study selection and characteristics 
1483 articles were identified, 52 were assessed with respect to their eligibility for inclusion 
(Supplementary Material 2) and 34 studies included in the systematic review (Table 1, Figure 1)15-
48. These 34 studies included 954 fetuses with a prenatal diagnosis of ovarian cysts. 
Quality assessment of the included studies was performed using Newcastle-Ottawa Scale (NOS) for 
cohort studies (Table 2). Most of the included studies showed an overall good rate with regard to 
the selection and comparability of the study groups and for the ascertainment of the outcome of 
interest. The main weaknesses of these studies were their retrospective design, small sample size 
and lack of detailed ultrasound characteristics of the cysts for some of the included studies.  
 
Synthesis of the results 
Resolution of the cysts 
Twenty-nine studies including   784 fetuses with a prenatal diagnosis of an ovarian cyst evaluated 
the rate of resolution of the cyst. About half of the cysts regress during pregnancy or after birth 
53.82% (95% CI 46.0-61.5). Resolution of the cyst occurred in  69.4% (95% CI 59.0-79.0) of 
simple cysts and in 84.8% (95% CI 70.0-95.2) of those measuring<40 mm. The proportions of 
resolution of ovarian cysts according to size and appearance are reported in Supplementary Table 3. 
Complex cysts and those ≥40 mm were less likely to regress than simple cysts or those measuring 
<40 mm (OR: 0.15, 95% CI 0.10-0.23)and OR: 0.03, 95% CI 0.01-0.06 respectively) (Table 3) 
(Figure 2). 
 
Change of US pattern, torsion and haemorrhage 
More than 20% (22.6%, 95% CI 14.4-34.4 ) of all simple cysts included in the present systematic 
review demonstrate change in the ultrasound pattern during pregnancy or at birth. The risk of 
change in the ultrasound pattern during pregnancy was significantly higher in cysts ≥ compared to 
those < 40 mm (OR: 3.16, 95% CI 1.02-9.7, I2: 0% ). In those cases, the occurrence of ovarian loss, 
either due to surgical removal or ovarian autoamputation, was high (pooled proportion: 57.7%, 95% 
CI 42.9—71.8, I2: 7.1% ) (Figure 2). 
 
The overall incidence of torsion of the cysts was 21.8%, (95% CI 15.2-29.2, (Figure 4). The 
corresponding figures for simple and complex cysts were 6.0% (95% CI 3.6-8.9) and 44.9% (95% 
CI 31.7-58.4)(Supplementary Table 4). The risk of ovarian torsion was significantly higher in cysts 
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≥ compared to those < 40 mm (OR: 30.8, 95% CI 8.6-110). Furthermore, the association between 
the complex appearance of the cyst at ultrasound and the occurrence of torsion was significantly 
higher than in case of simple cysts (OR: 16.2, 95% CI 4.3-61.6) . Cysts <40 mm, irrespective of 
their ultrasound appearance were less likely to be associated with torsion at birth (Table 4).  
The risk of haemorrhage was significantly higher in complex vs simple cysts (OR: 28.6, 95% CI 
4.9-∞), in those ≥40mm vs <40mm (OR: 31.7, 95% CI 3.71-270) and simple cysts ≥40mm vs <40 
mm (OR: 63.4 (10.7-∞ (Table 5) 
 
Surgery  
Thirty studies (761 fetuses) explored the incidence of surgery in fetuses with a prenatal diagnosis of 
ovarian cyst. They reported that 39.50 (95% CI 30.1-49.3of fetuses with a prenatal diagnosis of 
ovarian cysts confirmed at birth had surgical intervention. The corresponding figures in fetuses with 
simple and complex ovarian cysts were 24.6 (95% CI 14.2-36.9) and 64.8% (95% CI 52.2-76.3. The 
risk of having surgery was higher in patients with cysts ≥ compared to <40 mm (OR : 64.4, 95% CI 
23.6-175) and in complex cysts compared to simple cysts, irrespective of the cyst size (Table 6). 
 
The ultrasound appearance of the cyst was also associated with the type of surgical intervention and 
the likelihood of preserving the affected ovary (Supplementary Table 7). Both complex and large 
cysts (≥ 40 mm) were associated with a significantly increased risk of ovarian loss due to 
oophorectomy or salpingo-ophoorectomy (OR: 35.1, 95% CI 17.0-72.7)and OR: 58.9, 95% CI 19.2-
181, respectively) (Table 7). 
 
Intra-uterine treatment 
Twelve studies including 56 fetuses undergoing intra-uterine aspiration of the cyst were included in 
this systematic review. After aspiration of the cyst, the incidence of recurrence was 37.9% (95% CI 
14.8-64.3), while increase in the cyst size occurred in 6.9% (95% CI 2.0-14.5) of the cases. Almost 
half of the cyst aspirated in utero (48.9%, 95% CI 25.0-74.0) did not recur either during pregnancy 
or after birth. Change of ultrasound pattern of the cyst from a simple to complex appearance 
occurred in 7.9% (95% CI 2.6-15.8) of fetuses after aspiration of the cyst, while torsion and 
haemorrhage were diagnosed after birth in 10.8% (95% CI 4.4-19.7) and 9.7% (95% CI 3.7-18.3) of 
the cases treated. The rate of preterm birth or miscarriage due to the invasive procedure was 5.10% 
(95% CI 0.7-13.0); 1/44, I2:0%). Finally, 21.8% (95% CI 0.9-40) of fetuses undergoing fetal 
therapy had surgery after birth (Table 8).  
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False positive rate of prenatal ultrasound and histopathological diagnosis 
False positive rate of prenatal ultrasound in detecting ovarian cysts was 7.5% (95% CI 4.4-11.4). Of 
those cases misdiagnosed as ovarian cysts, almost half were gastrointestinal anomalies (54.1%, 95% 
CI 28.1-78.9). Furthermore, urogenital and renal anomalies were falsely diagnosed as ovarian cysts 
in 14.9% (95% CI 6.6-25.6) and 10.3% (95% CI 4.0-19.1) of the cases, respectively 
(Supplementary Table 8). 
 
Histopathogical assessment of the ovarian cyst following surgery was available for 385 cases. The 
majority of the cysts were either follicular or theca lutein (93.0%, 95% CI 87.7-96.8)) while 
cystoadenoma and teratoma were diagnosed in 2.1% (95% CI 0.9-3.7)and 1.5% (95% CI 0.5-2.9) of 
the cases (Supplementary Table 9). 
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DISCUSSION 
Main findings 
The findings from this systematic review showed that a large proportion of fetal ovarian cysts 
regress either during pregnancy or after birth. Simple cysts may change their ultrasound appearance 
and become complex during pregnancy and this is associated with an increased risk of ovarian loss. 
The size and appearance of the cyst are the major determinants of perinatal outcome and are 
associated with an increased risk of ovarian torsion, haemorrhage and need for oophorectomy. False 
positive rate of ultrasound in the detection of ovarian cysts is low, although it is not uncommon for 
gastro-intestinal, renal and urogenital anomalies to be misdiagnosed as ovarian. The very small 
number of included cases precluded extrapolating a robust evidence on the value of intra-uterine 
treatment of ovarian cysts.  
 
Strengths and limitations 
The small number of cases in some of the included studies, their retrospective non-randomized 
design, different periods of follow-up, dissimilarity of the populations (due to various inclusion 
criteria), the lack of fixed criteria for when to treat, and the post-natal confirmation represent the 
major limitations of this systematic review. The assessment of the potential publication bias was 
also problematic, both because of the outcome nature (rates with the left side limited to the value 
zero) which limits the reliability of funnel plots, and because of the scarce number of individual 
studies, which strongly limits the reliability of formal tests.  
 
Most of the observed outcomes were reported only by a limited proportion of the included studies. 
Furthermore, we could not stratify the analysis according to different cut-offs for cyst size in view 
of the fact that the majority of these were reported only by a few studies, thus considerably limiting 
the interpretation of the results. The ascertainment of some of the outcomes observed, such as 
surgery or need for oophorectomy was also considerably biased by the peculiar post-natal 
management adopted in different centers. Large lesions usually undergo surgical intervention 
irrespective of the presence of symptoms in order to reduce the risk of complications, such as 
torsion and hemorrhage which may lead to ovarian loss. In this scenario, the results from this 
systematic review may have over-estimated some of the adverse outcomes associated with ovarian 
cysts. 
 
The assessment of the role of intra-uterine therapy was also problematic. Ovarian cysts usually 
regress during pregnancy, thus the role of cyst aspiration in utero in preventing the occurrence of 
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torsion or haemorrhage could not be completely quantified. Furthermore, the very small number of 
included cases, different gestational ages at intervention and time points at the post-natal follow-up, 
lack of ascertainment according to cyst size and appearance did not allow us to draw any conclusion 
on the role of prenatal cyst aspiration in the management of ovarian cysts. Therefore, an adequately 
powered randomised control trial is needed in order to ascertain the value of prenatal cyst 
aspiration. 
Despite these limitations, the present review represents the best published estimate of the 
investigated outcomes in fetuses diagnosed with ovarian cysts. 
 
Implications for clinical practice 
Pre and post-natal management of ovarian cysts is challenging. The evidence is sparse and mainly 
derived from post-natal series reporting high rates of complications and need for surgical 
intervention. 
The findings from this systematic review showed that ultrasound appearance and cyst size are the 
major determinants of the perinatal outcome in these cases and can be used to tailor the optimal 
post-natal management of these patients.  
Simple cysts may occasionally change their ultrasound appearance and become complex either 
during pregnancy or after birth, and this was associated with a significantly increased risk of 
ovarian loss due to surgical oophorectomy or ovarian autoamputation. Ultrasound fetal surveillance 
should be arranged in order to look for early signs of complications of the cyst, such as an increase 
in size or appearance of intra-cystic echoes. However, the optimal perinatal management of these 
cases is controversial49,50. Iatrogenic preterm delivery and prompt surgical intervention may further 
compromise these patients on the basis that ovarian function might have already been compromised. 
In this scenario, especially in cases remote from term, ultrasound monitoring of the cyst seems the 
most reasonable and safe option. 
 
Complex cysts have been reported to be strongly associated with ovarian torsion requiring 
oophorectomy1,2. In the present review, the risk of surgical removal of the ovary was higher in large 
and complex cysts. Despite this, not all complex cysts showed signs of torsion, thus questioning 
whether immediate postnatal intervention should be arranged immediately after birth in children 
with complex lesions. 
 
The role of intra-uterine aspiration of ovarian cyst is controversial51. The findings from this 
systematic review suggest that almost half of the ovarian cysts aspirated in utero regress either 
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during pregnancy or after birth. Furthermore, the risk of torsion, haemorrhage and the need for post-
natal surgical intervention is relatively small. However, these findings come from retrospective 
series mainly including highly selected cases. The very small number of included studies, different 
time points at fetal intervention and follow-up, variation in cyst size and appearance did not allow 
us to draw any robust conclusion. Aspiration of the cyst in utero might be considered, especially in 
case of very large cysts presenting remote from term in order to not compromise the reproductive 
capacity of the woman or in case of the cyst causing compression on the adjacent structures leading 
to bowel obstruction or impaired flow in the ductus venosus. However, a randomised and 
adequately powered control trial is needed in order to ascertain the role, if any, of intra-uterine 
aspiration of the cyst in the prenatal management of ovarian cysts. 
 
Ovarian cysts are one of the most common abdominal cystic anomalies diagnosed prenatally.  The 
present review showed that a small proportion of renal, gastro-intestinal and genital anomalies can 
be misdiagnosed as ovarian. Almost 15% of complex urogenital anomalies, such as persistence of 
urogenital sinus or cloaca, were misdiagnosed as ovarian cysts. Because these anomalies are 
associated with worse postnatal and surgical outcomes compared to ovarian cysts, a thorough 
ultrasound examination should be arranged in order to not misdiagnosed them as ovarian cysts.  
 
CONCLUSION 
A large proportion of ovarian cysts diagnosed prenatally regress either during pregnancy or after 
birth. The risk of torsion is particularly high in case of large cysts. The change of ultrasound pattern 
during pregnancy is associated with a high risk of ovarian loss. The size and appearance of the cysts 
are the major determinants of perinatal outcome, and are associated with an increased risk of 
torsion, haemorrhage and need for oophorectomy. Future randomised trials are needed in order to 
ascertain the role of fetal therapy in the management of these cases. 
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Table 1. General characteristics of the included studies. 
 
Author Year Country Study 
Design 
Prenatal 
imaging 
Postnatal 
imaging 
GA at diagnosis 
(w) 
Cyst diameter 
(mm) 
Time at 
surgery 
Fetuses 
(n) 
Time at follow-
up 
           
Catania15 2015 Italy Retrospective US US. MRI 33 (22-39) NS NS 25 5y 
Thakkar16 2015 United 
Kingdom 
Retrospective US US NS NS NS 34 NS 
Nakamura17 2015 Japan Retrospective US US 32 (22-37) 47 (17-79) NS 33 NS 
Marchitelli18 2015 France Retrospective US US. MRI NS NS NS 17 NS 
Açıkgöz119 2015 Turkey Retrospective US US. MRI 30±6.4 39.8±13.4 NS 17 NS 
Jwa20 2015 Japan Retrospective US. MRI US 33.9 (29.9-36.9) 37 (15-52) 1d-4m 21 NS 
Papic21 2014 United 
Kingdom 
Retrospective US US NS 55.1 (24-150) 12w (3-64) 25 NS 
Karakus23 2014 Turkey Retrospective US US 33.1 (±3.2) 41.5 (10-60) NS 37 3m 
Turgal22 2013 Turkey Retrospective US US 28.4 (23-37) 40.9 (11-90) 2-4m 29 2-9m 
Amari24 2013 Germany Retrospective US NS 32+0 (14+6-39+2) NS NS 35 NS 
Dimitraki25 2012 Greece Retrospective US US 32.4 (30-37) 37.7 (21-74) 1m 16 3-12 m 
Gaspari26 2012 France Retrospective US US >32w 52.4 (40-60) 1-3m 5 4.14 y (1.5-6.7) 
Lecarpentier27 2012 France Retrospective US NS NS NS NS 26 NS 
Nemec28 2012 Austria Retrospective US. MRI US 31+2 (23+0-35+5) NS NS 16 NS 
Noia29 2012 Italy Retrospective US US 32 (27-36) 46 (31-74)  13 (2m-3y) 
Aqrabawi30 2011 Jordan Retrospective US US NS 30-100 NS 12 1m-6y 
Akin31 2010 Turkey Retrospective US US 34 (32-38) 53.0 (25-80) 1-23d 18 NS 
Eleftheriades32 2010 Greece Retrospective US US 32 (31+1-32+4) 37 (27-61) NT 7 NS 
Ben-Ami33 2010 Israel Retrospective US US 33 (28-37) 42.4 (10-60) 44.2d (1-115) 21 6.6 y (1.3-11.6) 
Zampieri34 2008 Italy Retrospective US US. MRI 34 (32-37) 50.0 (2.7-7.5) NS 57 1-5y 
Godinho35 2008 Portugal Retrospective US US 31.6 (29-35) 38.3 (29-60) 10-11d 5 NS 
Shimada36 2008 Japan Retrospective US US III trimester 46.6 (23-75) Within 10m 16 2m 
Monnery-
Nochè37 
2008 France Retrospective US US 33 (24-39) 43.5 (17-130) 3d(0-119d) 65 3m (11d-6y) 
Galinier38 2008 France Retrospective US US 32 (26-39) 43.5 (20-90) NS 79 11m (6-10y) 
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Kwak39 2006 South Korea Retrospective US US 34.0 (30-38) 49 (33-78) 1d-3w 17 1-24m 
Foley40 2005 Australia Retrospective US US II-III trimester 39.6 (0.7-7.0) 7-8m 11 12.9 m (3m-6y) 
Enriquez41 2005 Spain Retrospective US. MRI US. MRI (33-37) (2.4-11.2) NS 18 (3-15m) 
Comparetto42 2005 Italy Retrospective US US 34 (32-37) (27-75) NS 32 1-5y 
Quarello43 2003 France Retrospective US US 31 NS NS 12 NS 
Mittermayer44 2003 Germany Retrospective US US 32 (24-38) 42 (±12) 2h-6w 61 (7d-12m) 
Heling45 2002 Germany Retrospective US US 35 (26-40) 32 (17.5-55.0) 1-14d 64 NS 
Bagolan46 2002 Italy Prospective US US 33.6 (23-39) 39 (23-.85) NS 80 NS 
Perrotin47 2000 France Retrospective US US 31 (29-32) 31 (16-44) No surgery 3 2-4w 
Luzzatto48 2000 Italy Retrospective US US 33 (28-36) 43.3 (24-77) 0-17m 27 (3m-9y) 
           
NS: NS 
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Table 2. Quality assessment of the included studies according to Newcastle-Ottawa Scale (NOS) a 
study can be awarded a maximum of one star for each numbered item within the Selection and 
Outcome categories. A maximum of two stars can be given for Comparability. 
Author Year Selection Comparability Outcome 
   
Catania15 2015    
Thakkar16 2015    
Nakamura17 2015    
Marchitelli18 2015    
Açıkgöz119 2015    
Jwa20 2015    
Papic21 2014    
Karakus23 2014    
Turgal22 2013    
Amari24 2013    
Dimitraki25 2012    
Gaspari26 2012    
Lecarpentier27 2012    
Nemec28 2012    
Noia29 2012    
Aqrabawi30 2011    
Akin31 2010    
Eleftheriades32 2010    
Ben-Ami33 2010    
Zampieri34 2008    
Godinho35 2008    
Shimada36 2008    
Monnery-Nochè37 2008    
Galinier38 2008    
Kwak39 2006    
Foley40 2005    
Enriquez41 2005    
Comparetto42 2005    
Quarello43 2003    
Mittermayer44 2003    
Heling45 2002    
Bagolan46 2002    
Perrotin47 2000    
Luzzatto48 2000    
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Table 3: Pooled odd ratios showing the likelihood of resolution of fetal ovarian cysts according to cysts size and/or US appearance. 
 
 Studies 
(n) 
Fetuses 
(n/N Vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity* 
(95% CI) 
Specificity* 
(95% CI) 
      
Complex vs simple cysts 20 68/224 vs 231/341 0.15 (0.10-0.23) <0.001 58.6 (52.5-64.6) 77.3 (72.0-81.8) 
≥40mm vs <40mm cysts 16 60/192 vs 149/168  0.03 (0.01-0.06) <0.001 87.4 (80.8-92.1) 71.3 (64.6-77.2) 
Simple cysts ≥40mm vs <40 mm 16 45/134 vs 140/156 0.02 (0.00-0.06) <0.001 84.8 (76.1-90.8) 75.7 (68.7-81.5) 
Complex cysts ≥40mm vs <40 mm 9 (17/54 vs 25/28) 0.06 (0.01-0.21) <0.001 92.5 (78.5-98.0) 59.5 (43.3-74.0) 
Complex cysts ≥40 mm vs simple cysts ≥40mm 11 (19/60 vs 42/83) 0.40 (0.18-0.88) 0.022 50.0 (38.8-61.2) 68.9 (55.6-79.8) 
Complex cysts <40mm vs simple cysts ≥40mm  11 (26/30 vs 39/73) 4.93 (1.36-17.8) 0.015 10.5 (3.0-25.7) 60.0 (47.1-71.7) 
Complex cysts ≥40mm vs simple cysts <40mm  12 (20/62 vs 71/83) 0.04 (0.01-0.12) <0.001 77.8 (64.1-87.5) 78.0 (67.9-85.7) 
Complex cysts <40mm vs simple cysts <40mm 11 (26/30 vs 64/74) 0.56 (0.09-3.38) 0.5 25.6 (9.6-58.0) 71.1 (60.5-79.9) 
      
 
* Both sensitivity and specificity have been computed for the reversed outcome "No resolution". 
 
 
 
Table 4: Pooled odd ratios showing the likelihood of torsion of fetal ovarian cysts according to cysts size and/or US appearance. 
 
 Studies (n) 
Fetuses 
(n/N Vs n/N) 
Pooled OR 
(95% CI) p 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
       
Complex vs simple cysts 19 139/253 vs 7/242 59.1 (24.7-141) <0.001 95.2 (90.0-97.9) 67.3 (62.1-72.2) 
≥40mm vs <40mm cysts 13 45/116 vs 3/121 30.8 (8.6-110) <0.001 93.8 (81.8-98.4) 62.4 (55.1-69.3) 
Simple cysts ≥40mm vs <40 mm 12 (14/82 vs 1/123) 26.7 (3.3-214) 0.002 93.3 (66.0-99.7) 64.2 (56.9-70.9) 
Complex cysts ≥40mm vs <40 mm 9 (37/61 vs 3/33) 16.2 (4.3-61.6) <0.001 92.5 (78.5-98.0) 55.6 (41.5-68.8) 
Complex cysts ≥40 mm vs simple cysts ≥40mm 9 (37/61 vs 1/40) 82.0 (9.1-743) <0.001 97.4 (84.6-99.9) 61.9 (48.8-73.6) 
Complex cysts <40mm vs simple cysts ≥40mm  9 (3/35 vs 2/38) 1.8 (0.2-13.7) 0.6 60.0 (17.0-92.7) 52.9 (45.0-65.0) 
Complex cysts ≥40mm vs simple cysts <40mm  11 (38/66 vs 0/62) 114 (19.3-∞) * <0.001 100.0 (88.6-100.0) 68.9 (58.1-78.0) 
Complex cysts <40mm vs simple cysts <40mm 10 (3/39 vs 0/60) 6.2 (0.6-∞) * 0.11 100.0 (31.0-100.0) 62.5 (52.0-72.0) 
  
 
* Exact logistic regression, as no logistic regression model was possible due to zero event in the reference group (∞ = infinite). 
 
 
This article is protected by copyright. All rights reserved.
Ac
c
e
p
t
e
d
 
A
r
t
i
c
l
e
Table 5: Pooled odd ratios showing the risk of haemorrhage of fetal ovarian cysts according to cysts size and/or US appearance. 
 
 Studies 
(n) 
Fetuses 
(n/N Vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
       
Complex vs simple cysts 17 19/210 vs 0/205 28.6 (4.9-∞)* <0.001 100.0 (79.1-100.0) 51.8 (46.7-56.8) 
≥40mm vs <40mm cysts 12 2/15 vs 0/35 31.7 (3.71-270) 0.002 100.0 819.8-100.0) 72.9 (57.9-84.3) 
Simple cysts ≥40mm vs <40 mm 10 (20/70 vs 0/115) 63.4 (10.7-∞) * <0.001 100.0 (80.0-100.0) 69.7 (62.0-76.5) 
Complex cysts ≥40mm vs <40 mm 7 (5/44 vs 1/26) 2.8 (0.3-28.5) 0.4 83.3 (36.5-99.1) 39.1 (27.4-52.1) 
Complex cysts ≥40 mm vs simple cysts ≥40mm 7 (5/44 vs 0/28) 4.64 (0.60-∞) * 0.16 100.0 (46.3-100.0) 41.8 (30.1-54.5) 
Complex cysts <40mm vs simple cysts ≥40mm  7 (1/28 vs 0/26) 0.9 (0.0-∞) * 0.9 100.0 (5.5-100.0) 49.1 (35.3-63.0) 
Complex cysts ≥40mm vs simple cysts <40mm  9 (7/49 vs 0/54) 11.9 (1.72-∞) * 0.009 100.0 (56.1-100.0) 56.3 (45.8-66.2) 
Complex cysts <40mm vs simple cysts <40mm 8 (1/32 vs 0/52) 1.6 (0.0-∞) * 0.8 100.0 (5.5-100.0) 62.7 (51.3-72.8) 
  
 
* Exact logistic regression, as no logistic regression model was possible due to zero event in the reference group (∞ = infinite). 
 
 
Table 6: Pooled odd ratios showing the likelihood of surgery according to cysts size and/or US appearance. 
 
 Studies 
(n) 
Fetuses 
(n/N Vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
       
Complex vs simple cysts 22 (197/290 vs 77/292) 14.6 (8.53-24.8) <0.001 71.9 (66.1-77.1) 69.8 (64.3-74.8) 
≥40mm vs <40mm cysts 15 (96/138 vs 9/140) 64.4 (23.6-175) <0.001 91.4 (83.9-95.8) 75.7 (68.5-81.8) 
Simple cysts ≥40mm vs <40 mm 14 (67/90 vs 1/133) 3998 (233-68,626) <0.001 98.5 (91.0-99.9) 85.2 (78.4-90.2) 
Complex cysts ≥40mm vs <40 mm 11 (56/75 vs 7/42) 48.8 (10.4-229) <0.001 88.9 (77.8-95.0) 64.8 (50.6-77.0) 
Complex cysts ≥40 mm vs simple cysts ≥40mm 11 (75/58 vs 23/48) 17.7 (4.39-71.3) <0.001 71.6 (60.3-80.8) 59.5 (43.3-74.0) 
Complex cysts <40mm vs simple cysts ≥40mm  11 (7/44 vs 23/46) 0.22 (0.06-0.76) 0.016 23.3 (10.6-42.7) 38.3 (26.4-51.8) 
Complex cysts ≥40mm vs simple cysts <40mm  13 (61/80 vs 1/72) 2015 (71.0-57,179) <0.001 98.4 (90.2-99.9) 78.9 (68.8-86.5) 
Complex cysts <40mm vs simple cysts <40mm 12 (7/48 vs 1/70) 45.3 (1.2-1722) 0.040 87.5 (46.7-99.3) 80.5 (74.3-85.5) 
       
 
 
Table 7: Pooled odd ratios showing the likelihood of ovarian loss at surgery (due to oophorectomy or salpingo-oophorectomy) according to cysts 
size and/or US appearance. 
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 Studies 
(n) 
Fetuses 
(n/N Vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
       
Complex vs simple cysts 20 (139/263 vs 17/276) 35.1 (17.0-72.7) <0.001 89.9 (82.9-93.3) 67.6 (62.4-72.2) 
≥40mm vs <40mm cysts 15 (76/138 vs 5/140) 58.9 (19.2-181) <0.001 93.8 (85.6-97.8) 68.5 (61.5-74.8) 
Simple cysts ≥40mm vs <40 mm 13 (26/84 vs 0/129) 80.3 (13.8-∞) * <0.001 100.0 (84.0-100.0) 69.0 (61.8-75.4) 
Complex cysts ≥40mm vs <40 mm 10 (42/62 vs 4/38) 21.8 (5.8-81.9) <0.001 91.3 (78.3-97.2) 63.0 (48.7-75.4) 
Complex cysts ≥40 mm vs simple cysts ≥40mm 10 (42/62 vs 10/62) 35.0 (5.93-206) <0.001 80.8 (67.0-89.9) 72.2 (60.2-81.8) 
Complex cysts <40mm vs simple cysts ≥40mm  10 (4/40 vs 10/40) 1.6 (0.2-13.8) 0.7 28.6 (9.6-58.0) 45.5 (33.3-58.1) 
Complex cysts ≥40mm vs simple cysts <40mm  12 (44/67 vs 0/68) ∞ (500-∞) * <0.001 100.0 (89.9-100.0) 74.7 (64.3-83.0) 
Complex cysts <40mm vs simple cysts <40mm 11 (4/44 vs 0/66) 8.4 (1.0-∞) * 0.047 100.0 (39.6-100.0) 62.3 (52.3-71.3) 
  
 
* Exact logistic regression, as no logistic regression model was possible due to zero event in the reference group (∞ = infinite) 
 
 
Table 8: Pooled proportions for the different outcomes observed in fetal ovarian cysts treated pre-natally. 
 
 Studies (n) Fetuses (n/N) Raw proportions (95% CI) I2 Pooled proportion (95% CI) 
      
Recurrence 12 19/56 33.93 (21.8-47.8) 74 37.88 (14.8-64.3) 
Resolution 12 31/56 55.36 (41.5-68.7) 70 48.86 (25.0-74.0) 
Increase of cyst size 12 2/56 3.57 (0.4-12.3) 0 6.90 (2.0-14.5) 
Change of US pattern 12 3/56 5.36 (1.1-14.9) 0 7.90 (2.6-15.8) 
Torsion 12 4/56 7.14 (2.0-17.0) 0 10.83 (4.4-19.7) 
Haemorrhage 12 5/56 8.93 (3.0-19.6) 35.3 9.72 (3.7-18.3) 
Surgery 12 9/56 16.07 (7.6-28.3) 40.5 21.81 (0.9-40) 
Preterm birth 6 1/44 2.27 (0.1-12) 0 5.10 (0.7-13.0) 
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FIGURE LEGEND 
 
 
Figure 1. Systematic review flowchart. 
Figure 2 (a-b). Pooled proportions for the occurrence of (a) resolution, (b) change of ultrasound 
pattern from simple to complex in fetuses with ovarian cysts. 
Figure 3 (a-d). Pooled proportions for the occurrence of (a) torsion, (b) haemorrhage (c) surgery 
and (d) need for oophorectomy in fetuses with ovarian cysts. 
Figure 4 (a-h). Pooled proportions for the occurrence of different perinatal outcomes in fetuses 
with ovarian cyst undergoing intra-uterine aspiration. 
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